Dream Team explores new therapies to regulate genes

submitted by: mdanderson

It's not always genetic damage that drives cancer, sometimes it's the chemical on-off switches known as epigenetic factors. MD Anderson's Jean-Pierre Issa explains.

Dream Team targets molecular factors common in women's cancers

submitted by: mdanderson

First clinical trials begin soon to test new drugs against ovarian, endometrial and breast cancers that harbor dysfunctional PI3K pathways. MD Anderson's Gordon Mills explains.

Dream Team looks to circulating tumor cells as cancer indicator

submitted by: mdanderson

Tumor genetics must be analyzed to personalize lung cancer treatment. Could escaped cancer cells replace invasive biopsies? MD Anderson's Roy Herbst explains.